C
Claude Ostermann
Researcher at Max Planck Society
Publications - 5
Citations - 470
Claude Ostermann is an academic researcher from Max Planck Society. The author has contributed to research in topics: Glucose transporter & Heuristic. The author has an hindex of 5, co-authored 5 publications receiving 393 citations.
Papers
More filters
Journal ArticleDOI
De novo branching cascades for structural and functional diversity in small molecules
Miguel Garcia-Castro,Lea Kremer,Lea Kremer,Christopher D. Reinkemeier,Christian Unkelbach,Carsten Strohmann,Slava Ziegler,Claude Ostermann,Kamal Kumar,Kamal Kumar +9 more
TL;DR: This work presents a de novo branching cascades approach wherein simple primary substrates follow different cascade reactions to create various distinct molecular frameworks in a scaffold diversity phase, highlighting the immense potential of cascade reactionsto deliver compound libraries enriched in structural and functional diversity.
Journal ArticleDOI
Chromopynones are pseudo natural product glucose uptake inhibitors targeting glucose transporters GLUT-1 and -3.
George Karageorgis,Elena S. Reckzeh,Elena S. Reckzeh,Javier Ceballos,Javier Ceballos,Melanie Schwalfenberg,Melanie Schwalfenberg,Sonja Sievers,Claude Ostermann,Axel Pahl,Slava Ziegler,Herbert Waldmann,Herbert Waldmann +12 more
TL;DR: It is shown that chromopynones define a glucose uptake inhibitor chemotype that selectively targets glucose transporters GLUT-1 and -3, inhibits cancer cell growth and promises to inspire new drug discovery programmes aimed at tumour metabolism.
Journal ArticleDOI
Design, Synthesis, and Phenotypic Profiling of Pyrano‐Furo‐Pyridone Pseudo Natural Products
Andreas Christoforow,Andreas Christoforow,Julian Wilke,Julian Wilke,Aylin Binici,Aylin Binici,Axel Pahl,Claude Ostermann,Sonja Sievers,Herbert Waldmann,Herbert Waldmann +10 more
TL;DR: Pyrano‐furo‐pyridone‐ and dihydropyran NP fragments in three isomeric arrangements are described, which reveal that PFPs induce formation of reactive oxygen species and are structurally novel inhibitors of mitochondrial complex I.
Journal ArticleDOI
Synthesis of Indomorphan Pseudo-Natural Product Inhibitors of Glucose Transporters GLUT-1 and -3.
Javier Ceballos,Javier Ceballos,Melanie Schwalfenberg,George Karageorgis,George Karageorgis,Elena S. Reckzeh,Elena S. Reckzeh,Sonja Sievers,Claude Ostermann,Axel Pahl,Magnus Sellstedt,Jessica Nowacki,Marjorie A. Carnero Corrales,Julian Wilke,Julian Wilke,Luca Laraia,Luca Laraia,Kirsten Tschapalda,Malte Metz,Dominik A. Sehr,Silke Brand,Konstanze F. Winklhofer,Petra Janning,Slava Ziegler,Herbert Waldmann,Herbert Waldmann +25 more
TL;DR: The design, synthesis, and biological evaluation of a collection of indomorphan pseudo‐NPs that combine biosynthetically unrelated indole‐ and morphan‐alkaloid fragments are described and underscore the importance of dual GLUT‐1 andGLUT‐3 inhibition to efficiently suppress tumor cell growth and the cellular rescue mechanism, which counteracts glucose scarcity.
Journal ArticleDOI
Maximum-Score Diversity Selection for Early Drug Discovery
TL;DR: A modified version of diversity selection, which is term Maximum-Score Diversity Selection, that additionally takes the estimated or predicted activities of the molecules into account and validates these theoretical differences on several data sets.